{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:38:18Z","timestamp":1790563098781,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thermal ablation has proven beneficial for hepatocellular carcinoma and possibly for colorectal liver metastases, but data is lacking for other liver metastases. Computer-assisted navigation can increase ablation efficacy and broaden its indications. We present our experience with percutaneous stereotactic image-guided microwave ablation (SMWA) for non-colorectal liver metastases (NCRLM), in form of a retrospective study including all SMWA for NCRLM from 2015 to 2017. Indication for SMWA was determined at a multidisciplinary tumorboard. End-points include recurrence, overall and liver-specific disease progression and complications. Twenty-three patients underwent 25 interventions for 40 lesions, including 17 neuroendocrine tumor, nine breast cancer, four sarcoma, two non-small cell lung cancer, three duodenal adenocarcinoma, one esophageal adenocarcinoma, one pancreatic adenocarcinoma, one ampullary carcinoma, one prostate carcinoma, and one renal cell carcinoma metastases. Median follow-up was 15 months (2\u201332). Incomplete ablation rate was 2.5% (1\/40), local recurrence rate 10% (4\/40). Three patients (12%) had minor complications. Overall disease progression was 73.9% (17\/23), median disease-free survival 7 months (0\u201326) and overall survival 18 months (2\u201339). SIMWA is feasible, safe and minimally invasive for NCRLM in selected patients. While it might offer an alternative to resection or palliative strategies, the oncological benefit needs to be evaluated in a larger patient cohort.<\/jats:p>","DOI":"10.1038\/s41598-019-50159-3","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T10:03:27Z","timestamp":1569405807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Percutaneous stereotactic image-guided microwave ablation for malignant liver lesions"],"prefix":"10.1038","volume":"9","author":[{"given":"St\u00e9phanie","family":"Perrodin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Lachenmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Kim-Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Candinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Banz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"key":"50159_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1245\/s10434-009-0686-z","volume":"17","author":"RC Martin","year":"2010","unstructured":"Martin, R. C., Scoggins, C. R. & McMasters, K. M. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol. 17, 171\u201378 (2010).","journal-title":"Ann Surg Oncol."},{"key":"50159_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000367747","volume":"4","author":"R Lencioni","year":"2015","unstructured":"Lencioni, R., de Baere, T., Martin, R. C., Nutting, C. W. & Narayanan, G. Image-guided ablation of malignant liver tumors: recommendations for clinical validation of novel thermal and non-thermal technologies \u2013 a western perspective. Liver cancer. 4, 208\u201314 (2015).","journal-title":"Liver cancer."},{"key":"50159_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1073274817729258","volume":"24","author":"D Zamora-Valdes","year":"2017","unstructured":"Zamora-Valdes, D., Taner, T. & Nagorney, D. M. Surgical treatment of hepatocellular carcinoma. Cancer Control. 24, 1\u201315 (2017).","journal-title":"Cancer Control."},{"key":"50159_CR4","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.ejso.2014.05.003","volume":"40","author":"J Engstrand","year":"2014","unstructured":"Engstrand, J. et al. A multiple microwave ablation strategy in patients with initially unresectable colorectal cancer liver metastases \u2013 A safety and feasibility study of a new concept. EJSO. 40, 1488\u201393 (2014).","journal-title":"EJSO."},{"key":"50159_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1477-2574.2012.00585.x","volume":"15","author":"RT Groeschl","year":"2013","unstructured":"Groeschl, R. T. et al. Recurrence after microwave ablation of liver malignancies: A single institution experience. HPB (Oxford). 15, 365\u2013371 (2013).","journal-title":"HPB (Oxford)."},{"key":"50159_CR6","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1097\/SLA.0000000000000234","volume":"259","author":"RT Groeschl","year":"2014","unstructured":"Groeschl, R. T. et al. Microwave ablation for hepatic malignancies, a multiinstitutional analysis. Ann Surg. 259, 1195\u20131200 (2014).","journal-title":"Ann Surg."},{"key":"50159_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4716-8","volume":"18","author":"RS Pujik","year":"2018","unstructured":"Pujik, R. S. et al. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) \u2013 a phase III single-blind prospective randomized controlled trial. BMC Cancer. 18, 821 (2018).","journal-title":"BMC Cancer."},{"key":"50159_CR8","doi-asserted-by":"publisher","unstructured":"Gurusamy, K. S., Ramamoorthy, R., Sharma, D. & Davidson, B. R. Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases, Cochrane Database Syst Rev, https:\/\/doi.org\/10.1002\/14651858 (April 15, 2009).","DOI":"10.1002\/14651858"},{"key":"50159_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","volume":"197","author":"JM Sarmiento","year":"2003","unstructured":"Sarmiento, J. M. et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 197, 29\u201337 (2003).","journal-title":"J Am Coll Surg."},{"key":"50159_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/jso.23462","volume":"109","author":"MC Tan","year":"2014","unstructured":"Tan, M. C. & Jarnagin, W. R. Surgical management of non-colorectal hepatic metastasis. J Surg Oncol. 109, 8\u201313 (2014).","journal-title":"J Surg Oncol."},{"key":"50159_CR11","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.surg.2010.09.014","volume":"148","author":"HY Akyildiz","year":"2010","unstructured":"Akyildiz, H. Y., Mitchell, J., Milas, M., Siperstein, A. & Berber, E. Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: Long\u2010term follow\u2010up. Surgery. 148, 1288\u201393 (2010).","journal-title":"Surgery."},{"key":"50159_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00423-016-1417-0","volume":"401","author":"VM Banz","year":"2016","unstructured":"Banz, V. M. et al. Intraoperative image-guided navigation system: development and applicability in 65 patients undergoing liver surgery. Langenbecks Arch Surg. 401, 495\u2013502 (2016).","journal-title":"Langenbecks Arch Surg."},{"key":"50159_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2214\/AJR.15.15803","volume":"208","author":"J Engstrand","year":"2017","unstructured":"Engstrand, J. et al. Stereotactic CT-guided percutaneous microwave ablation of liver tumors with the use of high-frequency jet ventilation: an accuracy and procedural safety study. Am J Roentgenol. 208, 193\u2013200 (2017).","journal-title":"Am J Roentgenol."},{"key":"50159_CR14","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s11548-018-1778-7","volume":"13","author":"LP Beyer","year":"2018","unstructured":"Beyer, L. P. et al. Stereotactically navigated percutaneous microwave ablation (MWA) compared to conventional MWA: a matched pair analysis. Int J Comput Assist radiol Surg. 13, 1991\u20131997 (2018).","journal-title":"Int J Comput Assist radiol Surg."},{"key":"50159_CR15","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00270-011-0200-4","volume":"35","author":"G Widman","year":"2012","unstructured":"Widman, G., Schullian, M. H., Haidu, M. & Bale, R. Stereotactic Radiofrequency ablation (SFRA) of liver lesions: technique effectiveness, safety and interoperator performance. Cardiovasc Intervent Radiol. 35, 570\u2013580 (2012).","journal-title":"Cardiovasc Intervent Radiol."},{"key":"50159_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo, D., Demartines, N. & Clavien, P. A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survery. Ann Surg. 240, 205\u20132013 (2004).","journal-title":"Ann Surg."},{"key":"50159_CR17","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1007\/s00464-017-5458-4","volume":"31","author":"P Tinguely","year":"2017","unstructured":"Tinguely, P. et al. Laparoscopic image-based navigation for microwave ablation of liver tumors \u2013 a multi-center study. Surg Endosc. 31, 4315\u201324 (2017).","journal-title":"Surg Endosc."},{"key":"50159_CR18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/ALN.0000000000001541","volume":"126","author":"EE Hurwitz","year":"2017","unstructured":"Hurwitz, E. E. et al. Adding examples to the ASA-physical status classification improves correct assignment to patients. Anesthesiology. 126, 614\u201322 (2017).","journal-title":"Anesthesiology."},{"key":"50159_CR19","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1148\/radiol.13130753","volume":"270","author":"TW Kang","year":"2014","unstructured":"Kang, T. W. et al. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes. Radiology. 270, 888\u2013899 (2014).","journal-title":"Radiology."},{"key":"50159_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s005950070071","volume":"30","author":"Y Kojima","year":"2000","unstructured":"Kojima, Y. et al. Portal vein thrombosis caused by microwave coagulation therapy for hepatocellular carcinoma: report of a case. Surg Today. 30, 844\u20138 (2000).","journal-title":"Surg Today."},{"key":"50159_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1148\/radiol.2016152508","volume":"281","author":"J Chang","year":"2016","unstructured":"Chang, J. et al. Effects of microwave ablation on arterial and venous vasculature after treatment of hepatocellular carcinoma. Radiology. 281, 617\u201324 (2016).","journal-title":"Radiology."},{"key":"50159_CR22","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s00270-014-1020-0","volume":"38","author":"SS Bhatia","year":"2015","unstructured":"Bhatia, S. S. et al. Is antibiotic prophylaxis for percutaneous radiofrequency ablation (RFA) of primary liver tumors necessary? Results from a single-center experience. Cardiovasc Intervent Radiol. 38, 922\u2013928 (2015).","journal-title":"Cardiovasc Intervent Radiol."},{"key":"50159_CR23","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.crad.2012.12.008","volume":"68","author":"J Ding","year":"2012","unstructured":"Ding, J. et al. Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and microwave ablative techniques. Clin Radiol. 68, 608\u201315 (2012).","journal-title":"Clin Radiol."},{"key":"50159_CR24","first-page":"317","volume":"3","author":"E Lahat","year":"2014","unstructured":"Lahat, E. et al. Complications after percutaneous ablation of liver tumors: a systematic review. Hepatobiliary Surg Nutr. 3, 317\u201323 (2014).","journal-title":"Hepatobiliary Surg Nutr."},{"key":"50159_CR25","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1007\/s00330-011-2222-3","volume":"21","author":"L Calzadilla Bertot","year":"2011","unstructured":"Calzadilla Bertot, L., Sato, M., Tateishi, R., Yoshida, H. & Koike, K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol. 21, 2584\u201396 (2011).","journal-title":"Eur Radiol."},{"key":"50159_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.amjsurg.2018.01.037","volume":"216","author":"V Hong","year":"2018","unstructured":"Hong, V., Rice, J., Sharma, D. & Martin, R. C. G. The use of IRE in multi-modality treatment for oligometastatic pancreatic cancer. Am J Surg. 216, 106\u2013110 (2018).","journal-title":"Am J Surg."},{"key":"50159_CR27","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jamcollsurg.2011.12.048","volume":"214","author":"RT Groeschl","year":"2012","unstructured":"Groeschl, R. T. et al. Hepatectomy for noncolorectal nonneuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg. 214, 769\u2013777 (2012).","journal-title":"J Am Coll Surg."},{"key":"50159_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jvir.2012.11.021","volume":"24","author":"T Yamanaka","year":"2013","unstructured":"Yamanaka, T. et al. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor. J vasc Interv Radiol. 24, 341\u201346 (2013).","journal-title":"J vasc Interv Radiol."},{"key":"50159_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.clbc.2016.12.012","volume":"17","author":"N Golse","year":"2017","unstructured":"Golse, N. & Adam, R. Liver metastases from breast cancer: what role for surgery? Indications and results. Clinical breast cancer. 17, 256\u201365 (2017).","journal-title":"Clinical breast cancer."},{"key":"50159_CR30","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ejso.2013.03.023","volume":"39","author":"J Chen","year":"2013","unstructured":"Chen, J. et al. Radiofrequency ablation for liver metastasis from gastric cancer. Eur J Surg Oncol. 39, 701\u2013706 (2013).","journal-title":"Eur J Surg Oncol."},{"key":"50159_CR31","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s10120-015-0522-z","volume":"19","author":"A Guner","year":"2016","unstructured":"Guner, A. et al. Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation. Gastric Cancer. 19, 951\u2013960 (2016).","journal-title":"Gastric Cancer."},{"key":"50159_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jvir.2012.01.080","volume":"29","author":"JB Park","year":"2012","unstructured":"Park, J. B. et al. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma. J Vasc Interv Radiol. 29, 635\u201341 (2012).","journal-title":"J Vasc Interv Radiol."},{"key":"50159_CR33","first-page":"1887","volume":"7","author":"M Xiangying","year":"2016","unstructured":"Xiangying, M. et al. Receptor conversion in metastatic breast cancer: a prognosticator of survival. Oncotarget. 7, 1887\u20131903 (2016).","journal-title":"Oncotarget."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50159-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50159-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50159-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:57:47Z","timestamp":1671285467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50159-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["50159"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-50159-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,25]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"St\u00e9phanie Perrodin, Anja Lachenmayer, Martin Maurer, Corina Kim-Fuchs and Vanessa Banz have no competing interests to disclose. Daniel Candinas is co-founder and shareholder in CAScination AG, manufacturer of the navigation technology under investigation in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13836"}}